EXECUTIVE COMPENSATION AND RETENTION AGREEMENT
Exhibit
10.7
RETENTION
AGREEMENT
THIS
AGREEMENT ("Agreement"), by and between COIL TUBING TECHNOLOGY HOLDINGS,
INC., a
Nevada corporation, (referred to herein as the "Company"), and XXXXX XXXXXXXX
(referred to herein as "Xxxxxxxx") is entered into this 1st day of July 2007
(the “Effective Date"). In consideration of the mutual covenants set forth
herein, the Company and Xxxxxxxx hereby agree as follows:
1. APPOINTMENT.
The Company hereby agrees to appoint and retain Xxxxxxxx as its President
and
Chief Executive Officer, and Xxxxxxxx agrees to serve the Company, in the
capacities described herein during the Period of Appointment (as defined
in
Section 2 of this Agreement), in accordance with the terms and conditions
of
this Agreement.
2. PERIOD
OF
APPOINTMENT. The term “Period of Appointment” shall mean the period which
commences on the Effective Date and, unless earlier terminated pursuant to
Section 6, ends on December 31, 2008; provided, however, that the Period
of
Appointment may be extended for up to two additional years by Xxxxxxxx. Each
annual extension shall occur automatically unless Xxxxxxxx provides the Company
in writing that he will not be exercising the annual extension by December
1 of
each year prior to the to-be-extended year. For example, the Period of
Appointment will automatically extend to December 31, 2009 unless Xxxxxxxx
provides notice that he will not be exercising the extension for 2009 on
or
before December 1, 2008.
3. DUTIES
DURING THE PERIOD OF APPOINTMENT.
a.
|
DUTIES.
During the Period of Appointment, Xxxxxxxx shall be employed by
the
Company and serve as its “President and Chief Executive Officer.” In such
capacities, Xxxxxxxx will perform such services as are customary
for a
president and chief executive officer. Nothing herein is intended
to
restrict the duties of Xxxxxxxx or limit him from serving in such
other
executive officer positions as the Board of Directors deems appropriate.
|
b.
|
SCOPE.
During the Period of Appointment, and excluding any periods of
vacation
and sick leave to which the office of President is entitled, Xxxxxxxx
shall devote full time and attention to the affairs of the
Company.
|
4. COMPENSATION
AND OTHER PAYMENTS.
a.
|
ANNUAL
SALARY. Annual salary shall be set at $120,000.00 per annum payable
in
regular installments but in no event less often than monthly.
|
b.
|
ANNUAL
INCREASES. If the Period of Appointment is extended beyond December
31,
2008 as provided in section 2 above, Xxxxxxxx'x annual salary will
be
increased in an amount to be determined by the Board of the Company
or a
Committee
of the Board of the Company, but in no event shall such increases
be in an
amount less than ten percent (10%).
|
c.
|
BONUSES.
Xxxxxxxx may participate in any and all bonus plans established
by the
Board or a Committee of the Board.
|
5. OTHER
BENEFITS.
a.
|
INCENTIVE
& RETENTION SHARES.
|
i.
|
RETENTION
SHARES. The Company will issue to Xxxxxxxx one million (1,000,000)
shares
of its common stock contemporaneously with Xxxxxxxx entering into
this
Agreement.
|
ii.
|
INCENTIVE
SHARES. At the end of the initial Period of Appointment and the
end of
each subsequent year or, at Xxxxxxxx'x option, within thirty (30)
days
thereafter, the Company will issue to Xxxxxxxx the number of shares
necessary to provide to Xxxxxxxx five percent (5%) of the issued
and
outstanding common stock of the Company. As a result, on December
31, 2008
or, at Xxxxxxxx'x option, within 30 days thereafter, the Company
will
issue the number of shares necessary to provide Xxxxxxxx five percent
(5%)
of the issued and outstanding common stock of the Company. Further,
if
Xxxxxxxx elects to extend the Period of Appointment to December
31, 2009,
on December 31, 2009 or, at Xxxxxxxx'x option, within 30 days thereafter,
the Company will issue the number of shares necessary to provide
Xxxxxxxx
an additional five percent (5%) of the issued and outstanding common
stock
of the Company. Similarly, if Xxxxxxxx elects to extend the Period
of
Appointment to December 31, 2010, on December 31, 2010 or, at Xxxxxxxx'x
option, within 30 days thereafter, the Company will issue the number
of
shares necessary to provide Xxxxxxxx an additional five percent
(5%) of
the issued and outstanding common stock of the Company. Such shares
will
be subject to any and all restrictions appropriate or necessary
to comply
with state or federal registration requirements.
|
b.
|
REGULAR
REIMBURSED BUSINESS EXPENSES. The Company shall promptly reimburse
Xxxxxxxx for all expenses and disbursements reasonably incurred
by
Xxxxxxxx in the performance of his duties hereunder during the
Period of
Appointment.
|
c.
|
BENEFIT
PLANS. Xxxxxxxx and his eligible family members shall be entitled
to
participate immediately (except for any Company plan which includes
or
requires a waiting period, in which event Xxxxxxxx shall be entitled
to
participate as soon as he is eligible under the terms of such plan),
on
terms no less favorable to Xxxxxxxx than the terms offered to other
employees, in any group and/or executive life, hospitalization
or
disability insurance plan, health program, vacation policy, pension,
profit sharing, ESOP, 401(k) and similar benefit plans (qualified,
non-qualified and supplemental) or other fringe benefits that may
be
offered by the Company as approved by the Board of Directors from
time to
time.
|
d.
|
HEALTH
INSURANCE. The Company shall provide Xxxxxxxx and his wife, whether
or not
he remains employed by the Company, health insurance until at least
December 31, 2010.
|
e.
|
PERQUISITES.
The Company shall provide Xxxxxxxx at least such perquisites as
are
commonly provided to other executives of the Company and are commiserate
with his Appointment.
|
6. TERMINATION.
a.
|
GENERAL.
Xxxxxxxx'x employment hereunder shall commence on the Effective
Date and
continue until the end of the term specified in section 2 above,
except
that the employment of Xxxxxxxx hereunder shall terminate prior
to such
time in accordance with the
following:
|
i.
|
DEATH
OR DISABILITY. Upon Xxxxxxxx’x death during the term of his employment
hereunder or, at the option of the Company, in the event of Xxxxxxxx’x
disability, upon thirty (30) days notice to
Xxxxxxxx.
|
ii.
|
FOR
CAUSE. For “Cause” immediately upon written notice by the Company to
Xxxxxxxx. A termination for Cause shall mean:
|
(1)
|
the
commission of an intentional act of dishonesty, fraud, misrepresentation,
misappropriation, or embezzlement by Xxxxxxxx which has a material
detrimental impact on the Company;
|
(2)
|
Xxxxxxxx’x
unauthorized use or disclosure of any Confidential Information
or trade
secrets of the Company which has a material detrimental impact
on the
Company;
|
(3)
|
a
significant violation by Xxxxxxxx of a law or regulation applicable
to the
Company’s business, which has a material detrimental impact on the Company
and which the Board of the Company reasonably determines does or
is
reasonably likely to cause material injury to the Company;
|
(4)
|
Xxxxxxxx’x
indictment of, or conviction of, or plea of nolo
contendere
or
guilty to a felony or any other crime which involves moral
turpitude;
|
(5)
|
Xxxxxxxx’x
continued failure, in the reasonable discretion of the Board, to
perform
the principal duties, functions and responsibilities of his position
(other than any such failure resulting from Xxxxxxxx’x disability) or to
follow the directives of the Board after written notice from the
Company
identifying the deficiencies
in performance and a reasonable cure period of not less than thirty
(30)
days of any breach capable of cure; gross negligence or willful
misconduct
in the performance of Xxxxxxxx’x duties;
or
|
(6)
|
a
material and willful breach of Xxxxxxxx’x fiduciary duties to the Company.
|
iii.
|
WITHOUT
CAUSE. Without Cause upon thirty (30) days written notice by the
Board of
Directors to Xxxxxxxx or upon Xxxxxxxx to the Board of Directors.
If
Xxxxxxxx terminates the Agreement for any reason, he shall have
no
liability to the Company or its subsidiaries or affiliates as a
result
thereof.
|
iv.
|
CONSTRUCTIVE
TERMINATION. Upon Xxxxxxxx’x Constructive Termination. Constructive
Termination of Xxxxxxxx’x employment with the Company will be deemed to
have occurred if Xxxxxxxx terminates his employment with the Company
within six (6) months following the date on which:
|
(1)
|
the
Company demotes Xxxxxxxx to a lesser position, either in title
or
responsibility;
|
(2)
|
the
Company decreases Xxxxxxxx’x pay below the highest level in effect at any
time Xxxxxxxx’x employment with the Company or reduces Xxxxxxxx’x benefits
below the levels in effect during Xxxxxxxx’x employment with the Company
(other than as a result of any amendment or termination of any
group or
other executive benefit plan, which amendment or termination is
applicable
to all executives of the Company or any inadvertent reduction in
benefits
that Company cures within thirty (30) days after receiving written
notice
of such reduction);
|
(3)
|
the
Company requires Xxxxxxxx to relocate to a principal place of business
more than fifty (50) miles from the principal place of business
occupied
by Company as of the date hereof;
|
(4)
|
the
Company is subject to a Change in Control, unless Xxxxxxxx accepts
an
appointment or employment with a successor to the Company; or
|
(5)
|
the
Company breaches any material term of this Agreement which is not
cured by
the Company within ten (10) days after receiving written notice
of such
breach.
|
b.
|
OBLIGATIONS
OF THE COMPANY UPON TERMINATION. The following provisions describe
the
obligations of the Company to Xxxxxxxx under this Agreement upon
termination of his Appointment. However, except as explicitly
provided in
this Agreement, nothing in this Agreement shall limit or otherwise
adversely affect any rights which Xxxxxxxx may have under applicable
law,
under any other agreement with the Company, or under any compensation
or
benefit plan, program, policy or practice of the
Company.
|
i.
|
TERMINATION
BY THE COMPANY FOR CAUSE OR RESIGNATION WITHOUT CAUSE. In the event
this
Agreement terminates by reason of the Company’s termination of Xxxxxxxx’x
Appointment as President and Chief Executive Officer of the Company
for
Cause or because of Xxxxxxxx’x resignation Without Cause, the Company
shall:
|
(1)
|
Pay
to Xxxxxxxx within ten (10) days any amount of Compensation (as
enumerated
in section 4 above) earned but not yet
paid;
|
(2)
|
Provide
Xxxxxxxx’x health insurance as obligated in section 5(d) above, until
December 31, 2010; and
|
(3)
|
If
such termination occurs during the initial term of the Period of
Appointment, issue to Xxxxxxxx the Incentive Shares provided for
in
section 5 above.
|
ii.
|
TERMINATION
BY THE COMPANY WITHOUT CAUSE, OR CONSTRUCTIVE TERMINATION. In the
event
this Agreement terminates by reason of the Company’s termination of
Xxxxxxxx’x Appointment as President and Chief Executive Officer of the
Company Without Cause or Xxxxxxxx is Constructively Terminated,
the
Company shall:
|
(1)
|
Pay
to Xxxxxxxx in a lump sum within ten (10) days the remaining amount
of
Compensation provided for in section 4 above through December 31,
2010
including any minimum annual increases and bonuses and an additional
one
hundred thousand dollars
($100,000);
|
(2)
|
Provide
Xxxxxxxx’x health insurance as obligated in section 5(d) above, until
December 31, 2010; and
|
(3)
|
Issue
to Xxxxxxxx the Incentive Shares provided for in section 5 above
for any
periods (2008, 2009 or 2010) on December 31 (or at Xxxxxxxx’x election,
within thirty (30) days thereafter) the appropriate number of shares
for
such period.
|
iii.
|
TERMINATION
BY DEATH OR DISABILITY OR XXXXXXXX’X TERMINATION FOR CAUSE. In the event
this Agreement terminates by reason of Xxxxxxxx’x Death or Disability or
because of Xxxxxxxx’x resignation For Cause, the Company
shall:
|
(1)
|
Pay
to Xxxxxxxx within ten (10) days any amount of Compensation (as
enumerated
in section 4 above) earned but not yet
paid;
|
(2)
|
Provide
Xxxxxxxx’x health insurance as obligated in section 5(d) above, until
December 31, 2010; and
|
(3)
|
Issue
to Xxxxxxxx the Incentive Shares provided for in section 5 above
for any
periods (2008, 2009 or 2010) on December 31 (or at Xxxxxxxx’x election,
within thirty (30) days thereafter) the appropriate number of shares
for
such period.
|
c.
|
MITIGATION.
In no event shall Xxxxxxxx be obligated to seek another appointment
or
employment or take any other action by way of mitigation of the
amounts
payable to the Xxxxxxxx under any of the provisions of this Agreement.
Any
severance benefits payable to Xxxxxxxx shall not be subject to
reduction
for any compensation received from another appointment or
employment.
|
7. INDEMNIFICATION.
To the extent practical, the Company shall maintain, for the benefit of Xxxxxxxx
and other executives directors and/or officers liability insurance. In addition,
Xxxxxxxx shall be indemnified by the Company against liability as an officer
and
President and Chief Executive Officer of the Company and any subsidiary or
affiliate of the Company to the maximum extent permitted by applicable law.
Xxxxxxxx’x rights under this Section shall continue so long as he may be subject
to such liability, whether or not this Agreement may have
terminated.
8. INVENTIONS;
ROYALTY FREE LICENSE.
a.
|
INVENTIONS
DEFINED. “Inventions” includes all rights to discoveries, inventions,
improvements, designs and innovations (including all data and records
pertaining thereto) that relate to the business of the Company,
whether or
not patentable, copyrightable or reduced to writing, that Xxxxxxxx
may
discover, invent or originate during the term of his employment
hereunder,
either alone or with others and whether or not during working hours
or by
use of the facilities of the
Company.
|
x.
|
XXXXXXXX
TO RETAIN RIGHTS. Xxxxxxxx is to retain or maintain any and all
rights to
Inventions.
|
c.
|
COMPANY
TO LICENSE. Xxxxxxxx will grant to the Company a license on substantially
the terms of the licensing agreement attached hereto as Exhibit
A.
|
d.
|
WAIVER
OF ROYALTIES. Throughout his Appointment under this Agreement,
Xxxxxxxx
will waive any and all royalties due to him by the Company under
a Waiver
of Royalties Agreement on substantially the terms of the agreement
attached hereto as Exhibit B.
|
9. CONFIDENTIAL
INFORMATION.
a.
|
ACKNOWLEDGMENT
OF PROPRIETARY INTEREST. Xxxxxxxx agrees that all Confidential
Information
learned by him during his employment with the Company, whether
developed
by Xxxxxxxx or in conjunction with others or otherwise, is and
shall
remain the exclusive property of the Company.
|
b.
|
CONFIDENTIAL
INFORMATION DEFINED. “Confidential Information” means all confidential and
proprietary information of the Company, to the extent such property
is the
property of the Company and not the property of Xxxxxxxx or another,
and that is not otherwise publicly available. “Confidential Information”
does not include the “Inventions” referenced in section 8. Without limited
the foregoing, Confidential Information includes the
following:
|
i.
|
Information
derived from reports, investigations, experiments, research and
work in
progress,
|
ii.
|
Methods
of operation,
|
iii.
|
Marketing
data,
|
iv.
|
Proprietary
computer programs and codes,
|
v.
|
Drawings
designs, plans and proposals,
|
vi.
|
Marketing
and sales programs,
|
vii.
|
Client
lists,
|
viii.
|
Historical
financial information and financial projections,
|
ix.
|
Pricing
formulae and policies,
|
x.
|
All
other concepts, ideas, materials and information prepared or performed
for
or by the Company, and
|
xi.
|
All
information related to the business, products, purchases or sales
of the
Company and any of its suppliers and
customers.
|
c.
|
COVENANT
NOT TO DIVULGE CONFIDENTIAL INFORMATION. The Company is entitled
to
prevent the disclosure of Confidential Information. The Company
agrees to
and will provide Confidential Information to Xxxxxxxx at the inception
of
his employment and Xxxxxxxx acknowledges and agrees that, during
the
course of his employment he will be exposed to, have access to,
and gain
knowledge of Confidential Information. As a portion of the consideration
for the employment of Xxxxxxxx and for the compensation being paid
to him
hereunder and thereafter to hold in strict confidence and not to
disclose
or allow to be disclosed or made available to any person, firm
or
corporation, other than to his professional advisors (who have
the
obligation to maintain the confidentiality of such information)
and to
persons engaged by the Company to further the business of the Company,
and
not to use except in the pursuit of the business of the Company,
the
Confidential Information, without the prior written consent of
the
Company.
|
d.
|
RETURN
OF MATERIALS. In the event of any termination or cessation of his
employment with the Company for any reason, or request by the Company
at
anytime, Xxxxxxxx shall promptly deliver to the Company all documents,
data and other information derived from or otherwise pertaining
to
Confidential Information. Xxxxxxxx shall not take or retain any
documents
or other information, or any reproduction or excerpt thereof, containing
or pertaining to any Confidential
Information.
|
10. GENERAL
a.
|
NOTICES.
All notices and other communications hereunder shall be in writing
or by
written telecommunication, and shall be deemed to have been duly
given
upon
delivery if delivered personally or via written telecommunication,
or five
days after mailing if mailed by certified mail, return receipt
requested
or by written telecommunication, to the relevant address set forth
below,
or to such other address as either of the parties shall have furnished
to
the other in writing in accordance
herewith:
|
If to the Company, addressed to: |
If
to the Xxxxx Xxxxxxxx addressed to:
|
00000
Xxxx Xxxx, Xxxxx X
Xxxxxx,
XX 00000
|
Xxxxx
Xxxxxxxx
00000
Xxxx Xxxx, Xxxxx X
Xxxxxx,
XX 00000
|
Notice
and communications shall be effective when actually received by the
addressee.
b.
|
WITHHOLDING.
All payments required to be made to Xxxxxxxx by the Company under
this
Agreement shall be subject to withholding, at the time payments
are
actually made to Xxxxxxxx and received by him, of such amounts,
if any,
relating to federal, state and local taxes as may required by
law.
|
c.
|
TAXES.
In the event that the aggregate of all payments or benefits made
or
provided to, or that may be made or provided to, Xxxxxxxx under
this
Agreement and under all other plans, programs and arrangements
of the
Company (the "Aggregate Payment") are determined to constitute
a
"parachute payment" or some other category of payment which results
in
special tax treatment, Xxxxxxxx and the Company shall cooperate
with each
other in connection with any proceeding or claim relating to the
existence
or amount of liability for the payment, and all expenses incurred
by
Xxxxxxxx in connection therewith shall be paid by the Company promptly
upon notice of demand from
Xxxxxxxx.
|
d.
|
REIMBURSEMENT
OF LEGAL EXPENSES. In the event that Xxxxxxxx is successful, whether
in
mediation, arbitration or litigation, in pursuing any claim or
dispute
involving Xxxxxxxx’x Appointment with the Company, including any claim or
dispute relating to (a) this Agreement, (b) termination of Xxxxxxxx’x
Appointment with the Company or (c) the failure or refusal of the
Company
to perform fully in accordance with the terms hereof, the Company
shall
promptly reimburse Xxxxxxxx for all costs and expenses (including,
without
limitation, attorneys' fees) relating solely, or allocable, to
such
successful claim.
|
e.
|
LAW
GOVERNING. This Agreement shall be governed under the laws of the
State of
Texas.
|
f.
|
SEVERABILITY.
If any provision hereof is held invalid or unenforceable by a court
of
competent jurisdiction, such invalidity shall not affect the validity
or
operation of any other provision and such invalid provision shall
be
deemed to be severed from the
Agreement.
|
g.
|
WAIVERS.
No delay or omission by either party in exercising any right, power
or
privilege hereunder shall impair such right, power or privilege,
nor shall
any single or partial exercise such right, power or privilege preclude
any
further exercise thereof or the exercise of any other right, power
or
privilege.
|
h.
|
COUNTERPARTS.
This Agreement may be executed in multiple counterparts, each of
which
shall be deemed an original, and all of which together shall constitute
one and the same document.
|
i.
|
CAPTIONS.
The captions in this Agreement are for convenience of reference
only and
shall not limit or otherwise affect any of the terms of provisions
hereof.
|
j.
|
REFERENCE
TO AGREEMENT. Use of the words “herein, “hereof,” “hereto,” “hereunder”
and the like in this Agreement refer to this Agreement only as
a whole and
not to any particular section or subsection of this Agreement,
unless
otherwise noted.
|
k.
|
SUCCESSORS.
This Agreement shall be binding on and shall inure to the benefit
of the
parties hereto, their heirs, administrators, successors, and
assigns.
|
l.
|
ASSIGNABILITY.
This Agreement and the rights and obligations thereunder may not
be
assigned by any act of either party or by operation of law without
the
prior written consent of each party. However, the Company may fulfill
its
obligation to compensate Xxxxxxxx through one or more of its wholly
owned
subsidiaires.
|
m.
|
GENDER
AND NUMBER. The masculine gender shall be deemed to denote the
feminine or
neuter genders, the singular to denote the plural, and the plural
to
denote the singular, where the context so permits.
|
COIL
TUBING TECHNOLOGY HOLDINGS,
INC.
|
XXXXX XXXXXXXX |
By:
/s/
Xxxxx Xxxxxxxx
Xxxxx
Xxxxxxxx, President and Chief Executive Officer
|
By:
/s/
Xxxxx Xxxxxxxx
Xxxxx
Xxxxxxxx
|
Exhibit
A
LICENSING
AGREEMENT
This
Agreement is made and entered into this 1st day
of
July, 2007, by and between Xxxxx X. Xxxxxxxx ("GRANTOR"), a natural person
residing in Houston, Xxxxxx County Texas, and Coil Tubing Technology Holdings,
Inc. (“GRANTEE”), a Nevada corporation with a mailing address of 00000 Xxxx
Xxxx, Xxxxx X, Xxxxxx, Xxxxx 00000.
Whereas,
GRANTOR
has invented, designed, and built a device and method for inducing relative
rotation in a remote location of an upper portion and a lower portion in
response to relative axial movement (the Subterranean Rotation-Inducing Device
and Method). GRANTOR has invented and designed various devices and methods
which
utilize similar techniques and are intended to serve similar or related
functions. Furthermore, GRANTOR has invested and designed various other devices
and methods, and anticipates inventing and designing various other devices
and
methods, which can be utilized by GRANTEE or its subsidiaries, but which may
or
may not utilize techniques similar to the Subterranean Rotation-Inducing Device
and Method. Some, but not all, of such devices have been built (as prototypes)
and have or will be tested. The Parties intend for all such devises and methods,
including devises and methods developed, invented or designed while GRANTOR
is
employed by GRANTEE or its subsidiaries, to be provided for an governed by
this
Licensing Agreement. Thus, collectively, all such devices and methods described
above are referred to herein as the “Invention.”
Whereas,
GRANTOR
filed a United States Patent Application, Serial Number 08/471,774, for the
device and method known as "Subterranean Rotation-Inducing Device and Method"
on
June 6, 1995. The United State Patent and Trademark Office granted a Patent
on
such Application by issuance of Patent Number 5,584,342. GRANTOR has also filed
provisional patent application 60/787,906 and and a non-provisional patent
application filing 11/693,568 for certain jet powered down hold driven tools.
GRANTOR anticipates that such additional devices and methods referred to above,
will require prosecution of U.S. and/or international Patent Applications.
Collectively, Patent Number 5,584,342 and provisional patent application
60/787,906 and patent application 11/693,568 and any and all additional Patent
Applications or Letters of Patent are referred to herein as the
“Application.”
Whereas,
GRANTEE
is desirous of obtaining and GRANTOR is willing to grant an exclusive license
to
manufacture, use, sell, rent, and otherwise similarly exploit GRANTOR'S interest
in the Invention, the Application, and any and all Letters Patent of the United
States or other jurisdiction which may be granted therefor.
NOW,
THEREFORE, in consideration of the payment by each party to the other of the
sum
of One Dollar ($1.00) and other good and valuable consideration, the receipt
of
which is hereby acknowledged, and in consideration of the covenants and
obligations hereinafter set forth to be well and truly performed, the Parties
hereby agree as follows:
I.
DEFINITIONS
1.01
"Sold,"
"sales," and "sell" shall include sales, rentals, leases, transfers,
consignments, and the like as well as any other commercial exploitation of
the
subject Invention Property Products. One example of such other commercial
exploitation is the use of the Invention Property Products without directly
charging for the Invention Property Products, but charging for services or
other
equipment related to the same job or the same customer.
1.02
The
"Invention Property" is the Invention, the Application, and any and all Letters
Patent of the United States or other jurisdiction which may be granted therefor
as well as all reissues, divisionals, continuations, extensions and renewals
thereof.
1.03
"Invention Property Products" shall mean the devices, methods, improvements
to
known devices, or improvements to known methods that incorporate the
Invention.
1.04 An
"Affiliate" is (1) any entity in which GRANTEE or any of its stockholders,
directors, or officers has a direct or indirect ownership interest (other than
insubstantial interests in publicly held companies) or (2) any entity which
directly or indirectly through one or more intermediaries, control, is
controlled by, or is under common control with GRANTEE.
II.
LICENSE GRANT
2.01
GRANTOR
hereby grants to GRANTEE the sole and exclusive right and license to
manufacture, use, sell, and otherwise similarly exploit the Invention Property
until the expiration of the Invention Property or any reissue thereof unless
sooner terminated in accordance with any provision hereof.
III.
ROYALTIES
3.01
As
compensation and as royalties for the transfer of rights in the Invention
Property including the disclosure of information not currently available to
the
public, and the know-how and trade secrets associated with the Invention,
GRANTEE agrees to pay GRANTOR as follows:
a.
|
A
Royalty of ten percent (10%) of the gross receipts derived by GRANTEE
from
all sales of Invention Property
Products.
|
b.
|
In
no event shall the amount of the Royalty referred to in paragraph
“a” be
less than $100,000 per year for each devise or method invented, designed
or built for which no Letter of Patent has been issued by the United
States or other jurisdiction.
|
c.
|
In
no event shall the amount of the Royalty referred to in paragraph
“a” be
less than $200,000 per year for each devise or method invented, designed
or built for which a Letter of Patent has
been
issued by the United States or other
jurisdiction.
|
d.
|
The
minimum annual royalties described in paragraphs “b” and “c” above are
measured at the end of each year, the year beginning on the anniversary
of
the Effective Date of this Agreement.
|
e.
|
Furthermore,
the minimum annual royalties described in paragraphs “b” and “c” shall be
prorated in any year in which Letters of Patent issue.
|
3.02
GRANTEE shall pay interest to GRANTOR upon any and all amounts of royalties
that
are at any time overdue and payable to GRANTOR at the maximum legal interest
rate permitted under Texas law. This provision does not constitute a waiver
or
authorization for late payment or, in any way, negate GRANTOR's right to
terminate the agreement for non-performance by GRANTEE.
3.03
Anything herein to the contrary notwithstanding, royalties with respect to
all
sales, transfers or consignments made by GRANTEE to an Affiliate (as herein
defined) or to any purchaser which
does not otherwise deal at arms-length with it, shall be computed on an amount
equal to the price at which GRANTEE, at the time of such sales, transfers or
consignments, would invoice the same or similar items to purchasers dealing
at
arms-length with GRANTEE.
3.04
Anything herein to the contrary notwithstanding, royalties with respect to
all
sales, transfers or consignments made by GRANTEE that amounts to other
commercial exploitation of the Invention Property Products wherein the gross
receipts or any portion thereof are not directly attributable to the Invention
Property Products shall be computed on an amount equal to the price at which
GRANTEE, at the time of such sales, transfers or consignments, would invoice
the
same or similar items.
3.05
GRANTEE shall have the right to conduct sales and services through a subsidiary
or related entity provided that each of GRANTEE and such subsidiary or related
entity shall be jointly and severally responsible for the payment of royalties
and for other obligations under this Agreement, and the gross selling price
subject to royalty shall be deemed the price at which Invention Property
Products are sold or resold by GRANTEE or by its subsidiary or related company,
whichever be the highest.
3.06
GRANTEE agrees to pay GRANTOR the full royalty set forth in paragraph 3.01
for
as long as the license is in effect.
3.07
GRANTEE agrees to use good faith and fair dealing in all dealings with GRANTOR.
This good faith requirement includes the covenant to use fair market value
in
all sales and in calculating all royalties.
3.08
On
Invention Property Products sold by another (not including Affiliates of
GRANTEE), royalties are calculated and reported on Invention Property Products
with the same conditions as if sold by GRANTEE.
IV.
TIME FOR ROYALTY PAYMENTS; ACCOUNTING RECORDS;
EXAMINATION
4.01
GRANTEE agrees to keep complete and correct account of the number of Invention
Property Products which have been sold, and the number of Invention Property
Products which have been ordered and manufactured, and also showing invoice
number, customer name and address, gross selling price for each Invention
Property Products sold, the total Gross Sales, and the amount of royalty
due.
4.02
Where GRANTEE contracts with another for the manufacture of Invention Property
Products, GRANTEE agrees to require the manufacturer to keep complete and
correct account of the number of Invention Property Products which have been
ordered and manufactured, and also showing the date and destination of each
shipment of Invention Property Products.
4.03
Within twenty (20) days after the end of each month, reports shall be made
by
the GRANTEE to the GRANTOR setting forth the number of Invention Property
Products which have been sold, and the number of Invention Property Products
which have been ordered and manufactured, and also showing the invoice number,
customer name and address, gross selling price for each Invention Property
Product sold, the total Gross Sales, and the amount of royalty due.
4.04
GRANTEE's remittance for the full amount of royalties due for such month, with
interest from the end of the month to the date of payment, shall accompany
such
reports.
4.05
GRANTOR or its representative shall have the right, not more often than once
each quarter, to examine GRANTEE's books of account at all reasonable times,
during normal business hours, to the extent and insofar as is necessary to
verify the accuracy of the above-mentioned reports. It is agreed that GRANTOR
shall have the privilege of having a certified public accountant audit all
statements of account, reports, etc. provided for in this Agreement to be made
by GRANTEE to GRANTOR and that GRANTEE shall place at the disposal of said
certified public accountant for the purposes of this paragraph any and all
records essential to the verification of such reports. The expense of such
audits and verifications shall be borne by GRANTOR, except that if any audit
shows a deficiency of more than five percent (5%) in the royalties reported
and
paid, then GRANTEE shall bear the cost of the audit.
4.06
GRANTOR agrees to hold strictly confidential all information concerning royalty
payments and reports and all information learned in the course of any audit
hereunder, except when it is necessary for GRANTOR to reveal such information
in
order to enforce its rights under this Agreement.
4.07
In
the event of termination of this Agreement for any reason whatsoever, GRANTEE
agrees to permit GRANTOR, its auditors, accountants or agents to inspect all
said records and books of GRANTEE and to investigate generally all transactions
of business carried on by GRANTEE pursuant to this Agreement and the license
hereby granted, for a period of six (6) months after such
termination.
V.
WARRANTIES BY GRANTOR
5.01
GRANTOR represents and warrants that it is the owner of the entire right, title
and interest in the licensed Invention Property, and that it has the sole right
to grant the licenses under the licensed Invention Property of the scope herein
granted.
5.02
GRANTOR represents and warrants that it has the right to enter into this
Agreement, and that there are no outstanding assignments, grants, licenses,
encumbrances, obligations or agreements, whether written, oral or implied,
inconsistent with this Agreement.
VI.
ENFORCEMENT OF LICENSED PATENTS
6.01
The
Parties hereto agree to keep a diligent watch for infringement of the Invention
Property and notify the other Party of any such infringement. The Parties will
use reasonable attempts to halt any such infringement. However, neither Party
shall be required to pursue an infringement action that the Party believes
is
frivolous or without merit under the circumstances. Thus, the parties will,
by
agreement based upon the circumstances at the time, pursue legal action against
alleged infringers of the Invention Property against whom both of the Parties
have a good faith, reasonable belief they will prevail. Based upon these
guidelines, should one of the Parties elect not to pursue the alleged infringer,
the other Party may pursue the alleged infringer at their own expense and for
their own benefit and shall have the right to retain the benefit of any and
all
judgments for themselves. If the Parties pursue an alleged infringer together,
the Parties will share in any expense and recovery from such lawsuit as agreed
in advance of commencing any legal action and based on the circumstances of
the
particular infringement. In the event that GRANTEE commences litigation on
its
own, without GRANTOR, GRANTEE has the right to join GRANTOR as a necessary
party
and to gain his cooperation in exchange for reasonable compensation of GRANTOR’S
costs. GRANTOR shall be entitled to be represented at any such proceedings,
commenced solely by GRANTEE, by GRANTOR’S own counsel, at GRANTOR’S own expense.
Should all patent(s) on the Invention be invalidated during an infringement
suit, the royalty rate shall be reduced as provided for herein. GRANTEE is
obligated to continue to make reports, payments, and accountings through this
period. A reduced rate, if appropriate, begins on the date any judgment
invalidating the patent(s) becomes final.
6.02
GRANTOR shall not be obligated to defend or save harmless GRANTEE in any suit,
damage claim, or demand based on actual or alleged infringement of any patent
or
any unfair trade practice resulting from the exercise or use of any right or
license granted hereunder. In the event that the GRANTEE’S right to use the
devices, methods, processes, and techniques shall be challenged by any person
or
company claiming patent infringement by use thereof, GRANTOR shall provide
such
information as GRANTOR may possess which GRANTOR deem necessary to show the
date
or dates of discovery of the devices, methods, processes, and techniques,
provided that GRANTOR will be compensated for any expense incurred in connection
therewith.
VII.
ASSUMPTION OF THE RISK BY GRANTEE
7.01
GRANTEE agrees to assume full responsibility for product liability claims
resulting from the sale or use of the Invention Property Products and hold
GRANTOR harmless from any liability therefor, to indemnify GRANTOR, and to
obtain sufficient liability insurance to cover any such claims.
VIII.
PATENT MARKING
8.01
GRANTEE agrees to xxxx permanently and legibly all Invention Property Products
sold by it under this Agreement with the notation "Patent Pending" or
“International Patent Pending” during the prosecution of any Patent
application.
8.02
Upon
issuance of a patent and thereafter during the patent term, GRANTEE agrees
to
xxxx permanently and legibly all Invention Property Products sold by it under
this Agreement with the notation "U.S. Patent No." or similar xxxx for patents
issued by another jurisdiction, followed by the patent number.
IX.
TERMINATION RIGHTS
9.01
The
rights granted to GRANTEE shall remain with GRANTEE throughout the life of
the
Invention Property or during the period of GRANTEE’S exploitation of any devise
or method of the Invention Property whichever is longer. At the end of the
term,
all rights immediately and automatically revert to GRANTOR, regardless of any
outstanding sublicenses. The obligation on the part of GRANTEE to make the
payments required shall continue regardless of the issuance, non-issuance,
or
invalidation of a patent for the Invention in accordance with the compensation
terms of this Agreement.
9.02
In
the event of any adjudication of bankruptcy, appointment of receiver by a court
of competent jurisdiction, assignment for the benefit of creditors, or levy
of
execution directly involving GRANTEE, GRANTOR may, at his option, terminate
this
Agreement upon not less than twenty (20) days notice to GRANTEE, provided,
however, that such termination shall not impair or prejudice any right or remedy
that GRANTOR might otherwise have under this Agreement.
9.03
GRANTOR may terminate this Agreement on ninety (90) days written notice to
GRANTEE if the quality of the Inventory Property Products is substandard as
reasonably determined by GRANTOR.
9.04
If
GRANTEE shall at any time commit any breach of any covenant, warranty or
agreement herein contained, including the obligation to pay royalties, or shall
misrepresent the product or misrepresent the applications of the product and
shall fail to remedy any such breach or misrepresentation of the product or
the
applications of the product within thirty (30) days after written notice thereof
by the GRANTOR, then GRANTOR may at his option, and in addition to any other
remedies that he may be entitled to, cancel this Agreement by notice in writing
to such effect or, alternatively, convert this license to a non-exclusive
license. If an initiated program does not remedy the breach within three (3)
months after the aforementioned written notice by the GRANTOR, then GRANTOR
may
at his option, and in addition to any other remedies that he may be entitled
to,
cancel this Agreement by notice in writing to such effect or, alternatively,
convert this license to a non-exclusive license.
9.05
If
GRANTEE is not doing its best to satisfy demands for the devices incorporating
the Invention Property as determined by the good faith belief of GRANTOR,
GRANTOR may elect to convert the license to a non-exclusive license with sixty
(60) day written notice given to GRANTEE. If GRANTOR does subsequently grant
any
other licenses, GRANTEE may terminate this Agreement by ninety (90) day written
notice to GRANTOR.
9.06
If
GRANTEE does not meet or exceed the minimum royalties requirement, GRANTOR
may
elect to terminate this Agreement or, alternatively, convert the license to
a
non-exclusive license with sixty (60) day written notice given to GRANTEE,
unless GRANTEE shall pay to GRANTOR by the end of that time the amount required
to meet the minimum royalties. If GRANTOR does subsequently grant any other
licenses, GRANTEE may terminate this Agreement by ninety (90) day written notice
to GRANTOR.
9.07
In
the event of termination of this Agreement for any reason, GRANTEE shall not
thereby be discharged from any liability or obligation to GRANTOR that accrued
on or prior to the date of the termination. All unpaid sums shall become due
and
payable immediately.
9.08
On
the termination of this Agreement for any reason, GRANTEE shall deliver to
GRANTOR all books, notes, drawings, writings, and other documents, samples
and
models relating to any improvements, trade secrets, or inventions that are
the
subject of this Agreement. On termination of this Agreement, if any patents
on
the Invention have not expired, then GRANTEE shall cease to exploit, use,
manufacture, or sell the Invention in any way. All confidential material shall
remain confidential.
X.
PAYMENT OF COSTS ASSOCIATED WITH THE INVENTION PROPERTY
10.01
GRANTEE agrees to pay all costs, including attorney’s fees and governmental
fees, associated with the prosecution, issuance, and maintenance of the
Invention Property.
10.02
GRANTEE shall pay the costs to GRANTOR or to an agent designated by GRANTOR
within twenty (20) days from written request by GRANTOR.
10.03
The
request for payment of costs shall include sufficient information to allow
GRANTEE to verify the cost. Information such as invoices and citations of
statutory provisions along with an explanation of why the statute applies are
examples of sufficient information but other information may
suffice.
XI.
FORCE MAJEURE
11.01
Neither of the parties hereto shall be liable in damages or have the right
to
cancel this Agreement for any delay or default in performing hereunder (other
than the non-payment of royalties or other payments due under the Agreement)
if
such delay or default is caused by conditions beyond its control including,
but
not limited to acts of God, government restrictions, wars or insurrections,
strikes, fires, floods, work stoppages, and/or lack of materials.
XII.
SEVERABILITY
12.01
Should any part or provision of the Agreement be held unenforceable or in
conflict with the law of any jurisdiction, the validity of the remaining parts
or provisions shall not be affected by such holding.
12.02
In
any litigation involving this Agreement, any court having jurisdiction thereof
is authorized to reform the agreement to conform as closely as possible to
the
original intent of the parties with respect to any subject matter found to
be
unenforceable or in conflict with any law.
XIII.
LIMITATION ON EFFECT OF WAIVER
13.01
A
waiver of any breach of any provision of this Agreement shall not be construed
as a continuing waiver of other breaches of the same or other provisions of
this
Agreement.
XIV.
NEGATION OF AGENCY
14.01
Nothing herein contained shall be deemed to create an agency, joint venture
or
partnership relation between the parties hereto. It is understood and agreed
that GRANTEE is not, by this Agreement or anything herein contained, constituted
or appointed the agent or representative
of GRANTOR for any purpose whatsoever, nor shall anything herein contained
be
deemed or construed as granting to GRANTEE any right or authority to assume
or
to create any obligation or responsibility, express or implied, for or on behalf
of or in the name of GRANTOR, or to bind GRANTOR in any way or manner
whatsoever.
XV.
ENTIRE AGREEMENT
15.01
This Agreement sets forth the entire agreement and understanding of the parties
relating to subject matter contained herein and merges all prior discussions
between them, and neither party shall be bound by a definition, condition,
warranty, or representation other than as expressly stated in this Agreement
or
as subsequently set forth in a writing signed by the party to be bound
thereby.
XVI.
NEGATION OF CERTAIN WARRANTIES
16.01
No
warranty or representation is given or made by GRANTOR (a) that Licensed Devices
are free from infringement of the patent rights of third parties; or (b) as
to
scope or validity of the Licensed Patent, other than the that described in
Section V of this Agreement.
XVII.
ASSIGNABILITY
17.01
GRANTEE agrees not to assign or transfer, by operation of law or otherwise,
its
interest in the Invention Property or its interest in this agreement to any
person, firm, or corporation without the written consent of the GRANTOR so
to
do. GRANTOR may require submission of any relevant information from GRANTEE
in
making such evaluation.
17.02
GRANTOR may assign or transfer, by operation of law or otherwise, its interest
his the Invention Property or its interest in this agreement to any person,
firm, or corporation without the associated obligations contained in this
Agreement.
XVIII.
SUBLICENSING
18.01
Should GRANTEE desire to sublicense all or any portion of the Invention
Property, GRANTEE shall submit to GRANTOR the name of the proposed sublicensee
financial, historical, and other information concerning the proposed sublicense
sufficient to allow GRANTOR to determine the business, financial, technological,
and other capabilities and stability of the proposed sublicensee, and true
copies of the agreement or agreements to be entered into with the
sublicensee.
18.02
GRANTOR shall within a reasonable time after submission of all of the foregoing,
approve or disapprove the proposed sublicensee. GRANTOR is under no obligation
to approve of any proposed sublicensee. GRANTOR may unreasonably withhold
approval of any sublicensee and his approval or disapproval shall be subject
to
his complete discretion and fiat.
18.03
Any
sublicense agreement shall incorporate the terms of this Agreement and shall,
inter
alia,
require
that the sublicensee acknowledge the primacy and validity of this Agreement,
require the sublicensee upon written notice from GRANTOR to make payments
required hereunder directly to GRANTOR, and provide for audit rights of the
sublicensee by GRANTOR equivalent to those provided in this
Agreement.
XIX.
GOVERNING LAW
19.01
This Agreement shall be interpreted and construed, and the legal relations
created herein shall be determined, in accordance with the laws of the State
of
Texas.
XX.
NOTICES
20.01
Notices, reports, statements, payments, etc. required or permitted under this
Agreement shall be in writing and shall for all purposes deemed to be fully
given and received upon deposit with the United States Post Office if sent
by
certified mail, postage prepaid, to the respective parties at the following
addresses:
to GRANTEE: |
00000
Xxxx Xxxx, Xxxxx X
Xxxxxx,
Xxxxx 00000
|
to GRANTOR: |
Xxxxx
X. Xxxxxxxx
00000
Xxxx Xxxx, Xxxxx X
Xxxxxx,
Xxxxx 00000
|
20.02
Either party hereto may change its address for the purposes of this Agreement
by
giving to the other party written notice of its new address.
XXI.
GENERAL ASSURANCES
21.01
The
parties agree to execute, acknowledge and deliver all such further instruments,
and do all such other acts, as may be necessary or appropriate in order to
carry
out the intent and purposes of this Agreement.
XXII.
COUNTERPARTS
22.01
This Agreement may be executed in one or more counterparts, each of which shall
be treated and deemed an original, but all of which together shall constitute
one and the same document.
XXIII.
EFFECTIVE DATE
23.01
This Agreement, regardless of the date of its execution shall be effective
as of
July 1, 2007. Such date is referred to herein as the “Effective Date.”
IN
WITNESS WHEREOF, the parties hereto have executed this Agreement this 1st day
of
July, 2007.
GRANTEE: |
/s/
Xxxxx
Xxxxxxxx
Xxxxx
X. Xxxxxxxx, President
|
GRANTOR:
|
/s/
Xxxxx
Xxxxxxxx
Xxxxx
X. Xxxxxxxx
|
Exhibit
B
WAIVER
OF ROYALTIES
This
Agreement is made and entered into this 1st day of July, 2007, by and between
Xxxxx X. Xxxxxxxx ("Xxxxxxxx"), a natural person residing in Houston, Xxxxxx
County Texas, and Coil Tubing Technology Holdings, Inc. (“CTT Holdings”), a
Nevada corporation with a mailing address of 00000 Xxxx Xxxx, Xxxxx X, Xxxxxx,
Xxxxx 00000.
Whereas,
Xxxxxxxx and CTT Holdings entered into a Licensing Agreement dated the 1st
day
of July, 2007, which granted CTT Holdings an exclusive license in various
devices and methods described therein.
Whereas,
the
Licensing Agreement required CTT Holdings to make various Royalty payments
to
Xxxxxxxx in exchange for and in consideration of his grant of an exclusive
license to CTT Holdings.
Whereas,
Xxxxxxxx and CTT Holdings have entered into an “Executive Compensation and
Retention Agreement” (“Employment Agreement”). Pursuant to the Employment
Agreement, Xxxxxxxx has agreed to waive any royalties due to him during his
employment.
Whereas,
it is
anticipated that Xxxxxxxx will continue to develop intellectual property which
will be exploited by CTT Holdings and its subsidiaries. Such intellectual
property is the subject matter of a Licensing Agreement between CTT Holdings
and
Xxxxxxxx.
Whereas,
it is
in the Parties best interest to clarify the ownership of such intellectual
property and their rights, obligations and responsibilities related thereto.
Whereas,
CTT
Holdings is desirous of obtaining a waiver of its royalty payment requirements
under the Licensing Agreement it has with Xxxxxxxx and Xxxxxxxx is desirous
of
retaining ownership of the intellectual property he develops while in the employ
of CTT Holdings.
NOW,
THEREFORE,
in
consideration of the payment by each party to the other of the sum of One Dollar
($1.00) and other good and valuable consideration, the receipt of which is
hereby
acknowledged, and in consideration of the covenants and obligations hereinafter
set forth to be well and truly performed, the Parties hereby agree as
follows:
I.
WAIVER OF ROYALTIES
1.01
Xxxxxxxx hereby waives all royalties required to be paid under the Licensing
Agreement between him and CTT Holdings dated July 1, 2007.
II.
EFFECT OF WAIVER OR TERMINATION OF WAIVER
2.01
For
so long as the waiver provided for herein is in effect, CTT Holdings will not
be
obligated to make any of the Royalty payments provided for in the Licensing
Agreement between CTT Holdings and Xxxxxxxx.
2.02
Immediately upon the occurrence of one of the events of termination described
below, the waiver of royalty payments provided for in the Licensing Agreement
between CTT Holdings and Xxxxxxxx shall become due from such termination date
and in subsequent periods as provided in such Licensing Agreement.
III.
TERMINATION
3.01
Xxxxxxxx’x waiver of royalty payments shall automatically cease in the event
that CTT Holdings, its subsidiaries, or any other affiliated or related
companies are adjudicated bankrupt, or upon the appointment of a receiver by
a
court of competent jurisdiction, assignment for the benefit of creditors, or
levy of execution directly involving CTT Holdings, its subsidiaries, or any
other affiliated or related companies.
3.02
If
CTT Holdings, its subsidiaries, or any other affiliated or related company
shall
at any time commit any breach of any covenant, warranty or agreement herein
contained, then Xxxxxxxx may at his option, and in addition to any other
remedies that he may be entitled to, terminate his waiver of royalty payments
by
notice in writing to such effect.
3.03
If,
pursuant to the Employment Agreement, Xxxxxxxx is no longer employed by CTT
Holdings, regardless of the reason for such termination (death, disability,
termination for cause
or
termination without cause), Xxxxxxxx’x waiver of royalty payments shall
automatically cease.
3.04
If
Xxxxxxxx ceases to be a member of the Board of Directors of XXX Xxxxxxxx,
Xxxxxxxx’s waiver of royalty payments shall automatically cease.
3.05
Any
termination of Xxxxxxxx’x waiver of royalties shall not impair or prejudice any
right or remedy that Xxxxxxxx might otherwise have.
3.06
Notwithstanding any other provisions in this Agreement, subsequent to any
termination event, Xxxxxxxx may elect to continue his waiver of royalty payments
in writing and after having been fully informed of the nature of the termination
event.
IV.
OWNERSHIP OF INTELLECTUAL PROPERTY
4.01
Subject to the Licensing Agreement between CTT Holdings and Xxxxxxxx, any
inventions, improvements, designs, notes, references incorporating or reflecting
any of the intellectual property developed by Xxxxxxxx as a result of him being
employed by CTT Holdings, shall belong exclusively to Xxxxxxxx.
4.02
Upon
Xxxxxxxx’x termination as an employee of CTT Holdings (or its subsidiaries) CTT
Holdings shall provide Xxxxxxxx with a complete list of any intellectual
property in which it asserts an ownership interest. In making this
determination, there will be a rebuttable presumption that any intellectual
property developed during by Xxxxxxxx as an employee, was the result of his
effort, and therefore, his intellectual property pursuant to paragraph 4.01.
Furthermore, such presumption will be conclusive as to any intellectual property
wherein Xxxxxxxx is indicated as the “inventor,” “designer,” “developer” or the
like on a document, filing or application to the United States Patent Office
or
similar governmental agency in another jurisdiction.
4.03
Nothing within this agreement shall abrogate CTT Holdings’, or its subsidiaries,
obligations to pay fees or expenses as described in the Licensing Agreement
between Xxxxxxxx and CTT Holdings.
V.
NON ASSIGNABILITY
5.01
Xxxxxxxx cannot assign any of the rights he has under the Licensing Agreement
between him and CTT Holdings without the prior written consent of the Board
of
Directors of CTT Holdings. Such written consent may not be unreasonable
withheld.
VI.
SEVERABILITY
6.01
Should any part or provision of the Agreement be held unenforceable or in
conflict with the law of any jurisdiction, the validity of the remaining parts
or provisions shall not be affected by such holding.
6.02
In
any litigation involving this Agreement, any court having jurisdiction thereof
is authorized to reform the agreement to conform as closely as possible to
the
original intent of the parties with respect to any subject matter found to
be
unenforceable or in conflict with any law.
VII.
LIMITATION ON EFFECT OF WAIVER
7.01
A
waiver of any breach of any provision of this Agreement shall not be construed
as a continuing waiver of other breaches of the same or other provisions of
this
Agreement.
VIII.
ENTIRE AGREEMENT
8.01
This
Agreement sets forth the entire agreement and understanding of the parties
relating to subject matter contained herein and merges all prior discussions
between them, and neither party shall be bound by a definition, condition,
warranty, or representation other than as expressly stated in this Agreement
or
as subsequently set forth in a writing signed by the party to be bound
thereby.
IX.
GOVERNING LAW
9.01
This
Agreement shall be interpreted and construed, and the legal relations created
herein shall be determined, in accordance with the laws of the State of
Texas.
X.
NOTICES
10.01
Notices, reports, statements, payments, etc. required or permitted under this
Agreement shall be in writing and shall for all purposes deemed to be fully
given and received upon deposit with the United States Post Office if sent
by
certified mail, postage prepaid, to the respective parties at the following
addresses:
to
CTT Holdings:
|
CTT
Holdings, Inc.
|
00000
Xxxx Xxxx, Xxxxx X
|
|
Xxxxxx,
Xxxxx 00000
|
to
Xxxxxxxx:
|
Xxxxx
X. Xxxxxxxx
|
00000
Xxxx Xxxx, Xxxxx X
|
|
Xxxxxx,
Xxxxx 00000
|
10.02
Either party hereto may change its address for the purposes of this Agreement
by
giving to the other party written notice of its new address.
XI.
GENERAL ASSURANCES
11.01
The
parties agree to execute, acknowledge and deliver all such further instruments,
and do all such other acts, as may be necessary or appropriate in order to
carry
out the intent and purposes of this Agreement.
XII.
COUNTERPARTS
12.01
This Agreement may be executed in one or more counterparts, each of which shall
be treated and deemed an original, but all of which together shall constitute
one and the same document.
XIII.
EFFECTIVE DATE
13.01
This Agreement, regardless of the date of its execution, shall be effective
as
of ______________, 2007. Such date is referred to herein as the “Effective
Date.”
IN
WITNESS WHEREOF, the parties hereto have executed this Agreement this 1st day
of
July, 2007.
BY:
/s/
Xxxxx
Xxxxxxxx
|
|
Xxxxx
Xxxxxxxx, President
|
|
/s/
Xxxxx
Xxxxxxxx
|
|
Xxxxx
X. Xxxxxxxx
|